Antidepressants have complex associations with longitudinal depressive burden in bipolar disorder
- PMID: 30795488
- DOI: 10.1016/j.jad.2018.12.074
Antidepressants have complex associations with longitudinal depressive burden in bipolar disorder
Abstract
Aims: Antidepressants are common in bipolar disorder (BD), but controversial due to questionable efficacy/tolerability. We assessed baseline antidepressant use/depression associations in BD.
Methods: Stanford BD Clinic outpatients, enrolled during 2000-2011, assessed with the Systematic Treatment Enhancement Program for BD (STEP-BD) Affective Disorders Evaluation, were monitored up to two years with the STEP-BD Clinical Monitoring Form while receiving naturalistic expert treatment. Prevalence/correlates of baseline antidepressant use in recovered (euthymic ≥8 weeks)/depressed patients were assessed. Kaplan-Meier survival analyses assessed times to depressive recurrence/recovery in patients with/without baseline antidepressant use, and Cox Proportional Hazard regression analyses assessed covariate effects.
Results: Baseline antidepressant use was significantly (albeit without Bonferroni multiple comparison correction) less among 105 recovered (31.4%) versus 153 depressed (44.4%) patients, and among recovered patients (again without Bonferroni correction), associated with Caucasian race, earlier onset, worse Clinical Global Impression scores, and hastened depressive recurrence (only if mood elevation episodes were not censored), driven by lifetime anxiety disorder, and more (even with Bonferroni correction) bipolar II disorder, lifetime anxiety and eating disorders, and core psychotropics. Baseline antidepressant use among depressed patients was associated with significantly (again without Bonferroni correction) older age, female gender, and more (even with Bonferroni correction) anxiolytics/hypnotics, complex pharmacotherapy, and core psychotropics, but no other unfavorable illness characteristic/current mood symptom, and not time to depressive recovery.
Limitations: Tertiary BD clinic referral sample receiving open naturalistic expert treatment. Analyses without/with Bonferroni correction.
Conclusions: Additional research is required to assess the complex associations between baseline antidepressant use and longitudinal depressive burden in BD.
Keywords: Antidepressant; Bipolar disorder; Depression; Illness characteristics; Longitudinal.
Copyright © 2019 Elsevier B.V. All rights reserved.
Similar articles
-
Lifetime anxiety disorder and current anxiety symptoms associated with hastened depressive recurrence in bipolar disorder.J Affect Disord. 2017 Sep;219:165-171. doi: 10.1016/j.jad.2017.05.007. Epub 2017 May 8. J Affect Disord. 2017. PMID: 28558363
-
Abnormal sleep duration associated with hastened depressive recurrence in bipolar disorder.J Affect Disord. 2017 Aug 15;218:374-379. doi: 10.1016/j.jad.2017.05.015. Epub 2017 May 8. J Affect Disord. 2017. PMID: 28500982 Free PMC article.
-
Differential prevalence and demographic and clinical correlates of antidepressant use in American bipolar I versus bipolar II disorder patients.J Affect Disord. 2018 Jul;234:74-79. doi: 10.1016/j.jad.2018.02.091. Epub 2018 Feb 27. J Affect Disord. 2018. PMID: 29524749
-
The evidence for antidepressant use in bipolar depression.J Clin Psychiatry. 2006;67 Suppl 11:18-21. J Clin Psychiatry. 2006. PMID: 17029492 Review.
-
Efficacy and safety of antidepressant's use in the treatment of depressive episodes in bipolar disorder - review of research.Psychiatr Pol. 2015;49(6):1223-39. doi: 10.12740/PP/37914. Psychiatr Pol. 2015. PMID: 26909398 Review. English, Polish.
Cited by
-
Altered dynamic neural activities in individuals with obsessive-compulsive disorder and comorbid depressive symptoms.Front Psychiatry. 2024 Aug 8;15:1403933. doi: 10.3389/fpsyt.2024.1403933. eCollection 2024. Front Psychiatry. 2024. PMID: 39176228 Free PMC article.
-
Pharmacological Treatment of Bipolar Depression: A Review of Observational Studies.Pharmaceuticals (Basel). 2023 Jan 25;16(2):182. doi: 10.3390/ph16020182. Pharmaceuticals (Basel). 2023. PMID: 37145986 Free PMC article. Review.
-
Untangling the complex relationship between bipolar disorder and anxiety: a comprehensive review of prevalence, prognosis, and therapy.J Neural Transm (Vienna). 2025 Apr;132(4):567-578. doi: 10.1007/s00702-024-02876-x. Epub 2025 Jan 4. J Neural Transm (Vienna). 2025. PMID: 39755917 Review.
-
Decreased gray matter volume and dynamic functional alterations in medicine-free obsessive-compulsive disorder.BMC Psychiatry. 2023 Apr 25;23(1):289. doi: 10.1186/s12888-023-04740-w. BMC Psychiatry. 2023. PMID: 37098479 Free PMC article.
-
Belief updating in bipolar disorder predicts time of recurrence.Elife. 2020 Nov 10;9:e58891. doi: 10.7554/eLife.58891. Elife. 2020. PMID: 33168133 Free PMC article.